-
公开(公告)号:US20190209507A1
公开(公告)日:2019-07-11
申请号:US16326250
申请日:2017-08-23
申请人: Atif DABDOUB
发明人: Atif DABDOUB
IPC分类号: A61K31/205 , A23L33/155 , A23L33/16 , A23L33/175 , A23L33/105 , A23L33/125 , A61K31/194 , A61K33/04 , A61K31/295 , A61K31/593 , A61K31/714 , A61K31/375 , A61K31/51 , A61K31/525 , A61K31/455 , A61K31/191 , A61K31/4415 , A61K31/4188 , A61K31/519 , A61K9/14 , A61K47/36 , A61K31/201 , A61K31/122 , A61K36/9066 , A61K36/752 , A61K31/352 , A61P13/12
CPC分类号: A61K31/205 , A23L2/52 , A23L33/105 , A23L33/125 , A23L33/15 , A23L33/155 , A23L33/16 , A23L33/175 , A23V2002/00 , A61K9/14 , A61K31/122 , A61K31/191 , A61K31/194 , A61K31/201 , A61K31/295 , A61K31/352 , A61K31/375 , A61K31/4188 , A61K31/4415 , A61K31/455 , A61K31/51 , A61K31/519 , A61K31/525 , A61K31/593 , A61K31/714 , A61K33/04 , A61K33/26 , A61K33/30 , A61K36/752 , A61K36/9066 , A61K47/36 , A61P13/12 , A23V2200/126 , A23V2250/0612 , A23V2250/1592 , A23V2250/161 , A23V2250/1626 , A23V2250/1642 , A23V2250/21 , A23V2250/704 , A23V2250/708 , A23V2250/7106
摘要: Provided herein is a nutritional supplement designed to support kidney and cardiac function as well as mitochondrial energy function needs in patients undergoing hemodialysis. This supplement replenishes essential vitamins and minerals that are lost during dialysis, does not contain compounds that may specifically cause harm to dialysis patients, and provides support for tissues undergoing oxidative stress.
-
公开(公告)号:US20190191754A1
公开(公告)日:2019-06-27
申请号:US16219510
申请日:2018-12-13
申请人: MANTRA PHARMA
发明人: Olivier PAQUET , Maxime DESLAURIERS
IPC分类号: A23L33/155 , A23L33/16 , A23L33/00
CPC分类号: A23L33/155 , A23L33/15 , A23L33/16 , A23L33/30 , A23V2002/00 , A23V2200/30 , A23V2200/332 , A23V2250/1578 , A23V2250/1586 , A23V2250/1588 , A23V2250/1592 , A23V2250/1598 , A23V2250/16 , A23V2250/1604 , A23V2250/1608 , A23V2250/161 , A23V2250/1612 , A23V2250/1614 , A23V2250/1626 , A23V2250/1642 , A23V2250/702 , A23V2250/7042 , A23V2250/7044 , A23V2250/7046 , A23V2250/705 , A23V2250/7052 , A23V2250/7054 , A23V2250/7056 , A23V2250/7058 , A23V2250/706 , A23V2250/708 , A23V2250/71 , A23V2250/7102 , A23V2250/7104 , A23V2250/7106 , A23V2250/712 , A23V2250/714 , A23V2250/72 , A61K33/06 , A61K45/06 , A61P3/02 , A61K2300/00
摘要: The present technology relates to a nutritional formulation for administration to bariatric individuals. The nutritional formulation comprises a multi-nutrients dosage unit; and a minerals dosage unit.
-
公开(公告)号:US20180332875A1
公开(公告)日:2018-11-22
申请号:US15965629
申请日:2018-04-27
申请人: AMERICO PUPPO
发明人: AMERICO PUPPO
IPC分类号: A23L7/122 , A23L7/10 , A23L7/135 , A23P20/18 , A23L33/135 , A23L33/175 , A23L33/18 , A23L33/155 , A23L33/15 , A23L33/16
CPC分类号: A23L7/122 , A23L7/101 , A23L7/135 , A23L33/135 , A23L33/15 , A23L33/155 , A23L33/16 , A23L33/175 , A23L33/18 , A23L33/185 , A23P20/18 , A23V2002/00 , A23Y2300/00
摘要: A food additive for improving sensory characteristics and providing nutritional value to cereals or cereal mixture with irregular surface, which consists of collagen peptides of terrestrial and marine animal origin, the composition of which is, in % by weight, from 14% to 18% essential amino acids, from 10% to 14% aspartic acid and from 18% to 22% glycine, from 23% to 27% proline and hydroxyproline, from 9% to 13% glutamic acid, from 6% to 10% arginine, and from 6% to 10% alamine, dissolved in 5% to 50% aqueous solution, which is used as a carrier for adding ingredients, to form a uniform glossy coating on the surface of cereals or cereal mixture.
-
公开(公告)号:US20180193312A1
公开(公告)日:2018-07-12
申请号:US15658719
申请日:2017-07-25
申请人: ChronoSyn, LLC
IPC分类号: A61K31/4045 , A61K31/593 , A61K31/122 , A61K31/194 , A61P19/10 , A61P15/00 , A23L33/155
CPC分类号: A61K31/4045 , A23L33/10 , A23L33/15 , A23L33/155 , A23L33/16 , A23V2002/00 , A23V2200/306 , A23V2250/7106 , A23V2250/7144 , A61K31/122 , A61K31/194 , A61K31/593 , A61P15/00 , A61P19/10 , A23V2250/1632 , A23V2250/30
摘要: The present invention is a nutraceutical formulation, intended for oral administration, comprising co-administered if not co-formulated melatonin together with at least one of strontium, Vitamin D, and Vitamin K or their analogues. The nutraceutical combination or formulation is designed to be taken by mouth within about two hours prior to bedtime, and in fact should not be taken at any other time. The combination therapy gives new and unexpectedly improved results compared to the administration of melatonin alone.
-
公开(公告)号:US20180160697A1
公开(公告)日:2018-06-14
申请号:US15889722
申请日:2018-02-06
申请人: VitaPerk LLC
IPC分类号: A23F5/24 , A23L33/10 , A23L33/155 , A23L33/16
CPC分类号: A23F5/243 , A23L33/10 , A23L33/155 , A23L33/16
摘要: The invention herein contemplates a nutritional additive composition providing health benefits and improved dissolution, appearance, and taste when added to solid food and liquids.
-
6.
公开(公告)号:US20180116933A1
公开(公告)日:2018-05-03
申请号:US15561428
申请日:2016-03-29
发明人: Yung Hyup JOO , Heung Soo BAEK , Jeong Ah HWANG , Hae Kwang LEE , Yongjin KIM , Hong-Ju SHIN , Jon Hwan LEE
IPC分类号: A61K8/42 , A61Q19/08 , A61K31/166 , A23L33/00 , A23L33/15 , A23L33/155 , A23L33/16 , A23L2/52
CPC分类号: A61K8/42 , A23L2/52 , A23L33/15 , A23L33/155 , A23L33/16 , A23L33/30 , A23V2002/00 , A61K8/30 , A61K8/34 , A61K31/166 , A61Q19/08
摘要: 5-Adamantan-1-yl-N-(2,4-dihydroxybenzyl)-2,4-dimethoxybenzamide disclosed in the present specification can exhibit excellent anti-oxidative and anti-aging effects while having no toxicity. For example, the compound exhibits excellent anti-oxidative and anti-aging effects by scavenging free radicals or inhibiting MMP-1 expression.
-
公开(公告)号:US09950071B2
公开(公告)日:2018-04-24
申请号:US15109621
申请日:2015-01-05
申请人: INDUSTRIAL COOPERATION FOUNDATION CHONBUK NATIONAL UNIVERSITY , KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY
发明人: Dong Won Lee , Byoung Mog Kwon , Joung Youn Noh , Byeng Su Kwon , Dong Cho Han
IPC分类号: C07D319/06 , A61K31/357 , A61K47/48 , A61K31/69 , A61K9/00 , A61K9/08 , A23L33/10 , A23L33/15 , A23L33/155 , A23L33/16 , A61K47/26 , A61K9/16 , A61K9/20 , C07F5/02 , A61K47/55
CPC分类号: A61K47/55 , A23L33/10 , A23L33/15 , A23L33/155 , A23L33/16 , A23V2002/00 , A61K9/0019 , A61K9/08 , A61K9/1611 , A61K9/1623 , A61K9/1652 , A61K9/2018 , A61K9/2059 , A61K31/69 , A61K47/26 , C07F5/025 , A23V2200/308
摘要: The present invention relates to a hybrid anticancer prodrug simultaneously producing cinnamaldehyde and quinone methide. The hybrid anticancer prodrug according to the present invention sequentially releases quinone methide and cinnamaldehyde by H2O2 and acidic pH, and thus alkylates antioxidant GSH through the release of quinone methide, thereby inhibiting an antioxidative system and increasing oxidation stress, and generates and accumulates reactive oxygen species (ROS) through the release of cinnamaldehyde, thereby promoting apoptosis, and thus the hybrid anticancer prodrug according to the present invention can be favorably used as an anticancer drug by creating a synergetic anticancer effect through double stimulus-response and sequential treatment action in a cancer cell-specific manner.
-
公开(公告)号:US20180021405A1
公开(公告)日:2018-01-25
申请号:US15672941
申请日:2017-08-09
发明人: MARVIN S. HAUSMAN
IPC分类号: A61K38/18 , A61K31/593 , A23L31/00 , A61K36/07 , A61K31/4172 , A61K31/592 , A61K31/4164 , A23L33/155 , A61K45/06
CPC分类号: A61K38/1816 , A23L31/00 , A23L31/10 , A23L33/155 , A23V2002/00 , A61K31/4164 , A61K31/4172 , A61K31/592 , A61K31/593 , A61K36/07 , A61K45/06 , A61K2300/00 , A23V2200/324 , A23V2250/208 , A23V2250/7104
摘要: Nutritional products, compositions, pharmaceutical preparations and methods of use are disclosed for the prevention, suppression and treatment of anemia and/or diabetes and its various associated comorbidities. Uses of Ergothioneine to neutralize free radicals and/or cytokines, reduce oxidative stress, prevent inflammation, stimulate red blood cell production with increased levels of hemoglobin, and/or stabilize iron in its normal 2+ charge for proper oxygen binding and carrying are further disclosed. The extraction of Ergothioneine from whole food sources and bacterium for use in nutritional products, compositions, pharmaceutical preparations and treatments is also disclosed.
-
公开(公告)号:US20180021353A1
公开(公告)日:2018-01-25
申请号:US15648911
申请日:2017-07-13
发明人: John Rathmacher , John Fuller, JR. , Shawn Baier , Steve Nissen , Naji Abumrad
IPC分类号: A61K31/59 , A23K20/00 , A23L33/155 , A23L33/10 , A23K20/174 , A23L33/15 , A23L33/00 , A61K31/19 , A61K31/593 , A23L33/175
CPC分类号: A61K31/59 , A23K20/00 , A23K20/174 , A23L33/10 , A23L33/15 , A23L33/155 , A23L33/175 , A23L33/30 , A23V2002/00 , A61K31/19 , A61K31/593 , A61K2300/00 , A23V2250/71 , A23V2200/316
摘要: The present invention provides a composition comprising HMB and Vitamin D. Methods of administering HMB and Vitamin D to an animal are also described. Vitamin D and HMB are administered to increase muscle mass, strength, and functionality. The combination of Vitamin D and HMB together has a synergistic effect, which results in a surprising and unexpected level of improvement in muscle mass, strength and functionality.
-
公开(公告)号:US20180008634A1
公开(公告)日:2018-01-11
申请号:US15709693
申请日:2017-09-20
申请人: Exeltis USA, Inc.
IPC分类号: A61K33/30 , A61K45/06 , A61K33/08 , A61K31/714 , A61K31/7135 , A61K31/59 , A61K31/525 , A61K31/519 , A61K31/51 , A61K31/455 , A61K31/4415 , A61K31/375 , A61K31/222 , A61K31/202 , A61K31/015 , A61K9/48 , A61K9/00 , A61K31/355
CPC分类号: A61K33/30 , A23L33/10 , A23L33/12 , A23L33/15 , A23L33/155 , A23L33/16 , A23L33/40 , A23V2002/00 , A61K9/0056 , A61K9/4825 , A61K9/4841 , A61K31/015 , A61K31/07 , A61K31/202 , A61K31/222 , A61K31/355 , A61K31/375 , A61K31/4415 , A61K31/455 , A61K31/51 , A61K31/519 , A61K31/525 , A61K31/59 , A61K31/7135 , A61K31/714 , A61K33/08 , A61K45/06 , Y10S514/904 , Y10S514/943 , A61K2300/00
摘要: The present invention relates to methods of co-administration of various vitamins and mineral compositions, and in a specific embodiment, said methods comprise co-administering one composition comprising vitamin A, beta carotene, B-complex vitamins, vitamin C, vitamin D3, vitamin E, iron, magnesium and zinc, and a second composition comprising omega-3 fatty acids such as DHA, to supplement the nutritional needs of individuals within physiologically stressful states; and kits provided for co-administration of various vitamin and mineral compositions, and in a specific embodiment, said kits comprise one composition comprising vitamin A, beta carotene, B-complex vitamins, vitamin C, vitamin D3, vitamin E, iron, magnesium and zinc, and a second composition comprising omega-3 fatty acids, such as DHA, to supplement the nutritional needs of individuals within physiologically stressful states.
-
-
-
-
-
-
-
-
-